Safety and Tolerability of Elbasvir/Grazoprevir in Patients with
Chronic Hepatitis C: An Integrated Analysis of Phase 2-3 Trials
Reported by Jules Levin
APASL 2016 Tokyo Feb 20-24
Michael P. Manns, Geoffrey M. Dusheiko, John M. Vierling, K. Rajender Reddy, Mark Sulkowski, Paul Kwo, Eric Lawitz, Deborah D. Brown, Stephanie O. Klopfer, Michael Robertson, Janice Wahl, Eliav Barr, Barbara Haber, Edgar D. Charles
